U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 25

Tests names and labsConditionsGenes, analytes, and microbesMethods

F12 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoImmuno Panel

Centogene AG - the Rare Disease Company
Germany
323329
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Atypical Hemolytic Uremic Syndrome (aHUS) Panel

Centogene AG - the Rare Disease Company
Germany
2325
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Blood Coagulation Panel

Centogene AG - the Rare Disease Company
Germany
110112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Invitae Hereditary Angioedema Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
54
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Angioedema, hereditary, type III, 610618, Autosomal dominant; HAE3 (Hereditary angioedema) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Angioedema, hereditary, type III, 610618, Autosomal dominant; HAE3 (Hereditary angioedema) (F12 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

F12 mutation analysis

Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center
Netherlands
11
  • E Sequence analysis of select exons

Clotting factor deficiency panel. 16-gene NGS panel.

Genologica Medica
Spain
2916
  • C Sequence analysis of the entire coding region

Bleeding disorder / coagulopathy panel. NGS panel of 62 genes.

Genologica Medica
Spain
9662
  • C Sequence analysis of the entire coding region

Angioedema, hereditary: Full gene sequencing panel

CEN4GEN Institute for Genomics and Molecular Diagnostics
Canada
44
  • C Sequence analysis of the entire coding region

Angioedema, hereditary, type III

Duzen Laboratories Duzen BBAGUAS
Turkey
11
  • C Sequence analysis of the entire coding region

Comprehensive Thrombotic Microangiopathy NGS Panel

Fulgent Genetics
United States
5837
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Thrombosis, Platelet Disorder, and Coagulation Deficiency NGS Panel

Fulgent Genetics
United States
14682
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Focus Thrombotic Microangiopathy NGS Panel

Fulgent Genetics
United States
4022
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Coagulation Disorders

Asper Biogene Asper Biogene LLC
Estonia
2116
  • C Sequence analysis of the entire coding region

Vascular and lymphatic disorders Panel

CeGaT GmbH
Germany
1718
  • C Sequence analysis of the entire coding region

Single gene testing F12

CeGaT GmbH
Germany
21
  • C Sequence analysis of the entire coding region

F12 Single Gene

Fulgent Genetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Coagulation Deficiency NGS Panel

Fulgent Genetics
United States
5624
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 25

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.